Bioassays Workshop

Introduction to Bioassay Development: CMC Strategy and Practical Application | Morning Session

Monday, April 27, 2026 | 08:00 - 13:00 EDT
Facilitators: Scott Umlauf and Patrick Hussmann, AstraZeneca

The workshop will provide practical knowledge on bioassay method development, with a particular emphasis on potency assays. Method development and lifecycle management will be covered in the context of the unique role of bioassays in CMC control strategy of biopharmaceuticals, including monoclonal antibodies, antibody-drug conjugates, fusion proteins, such as T cell engagers, vaccines, and cell and gene therapy. 

Practical Applications for Method Design and Performance | Afternoon Session

Monday, April 27, 2026 | 13:00 - 17:00 EDT
Facilitators: Colleen Santoro and Victoria Swiss, Bristol-Myers Squibb Company

In this interactive session, participants will work collaboratively on case studies relevant to current challenges in bioassay development, deployment, and lifecycle.  This session will expand on the morning session and is recommended for both novice and experienced attendees.

Note: Registration for the workshop requires an additional ticket which can be added to your registration at the time of purchase. For additional information on pricing, view Registration Fees.